
Clinical UpdatesPolypoidal Choroidal VasculopathyOCT Biomarkers
Outcomes of As-Needed Aflibercept Treatment After Complete Regression in Polypoidal Choroidal Vasculopathy: A Clinical Review
By MedXY|Sep 22, 2026
This review synthesizes evidence on PRN aflibercept treatment after complete polypoidal regression in PCV, highlighting recurrence rates, visual outcomes, and potential OCT biomarkers guiding individualized management.
